Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainChronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western Hemisphere, affecting approximately 20

Updated on: February 08,2026

Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainChronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western Hemisphere, affecting approximately 20

Updated on:February 08,2026

Prioritizing potentially cancer-causing mutations in real-world cancer genomics

byHiroshima UniversityOverview of a framework for prioritizing variants of uncertain significance (VUS) identified by comprehensive genomic profiling (CGP), based on real-world data from 2,172 tests s

Updated on: June 09,2026

Prioritizing potentially cancer-causing mutations in real-world cancer genomics

byHiroshima UniversityOverview of a framework for prioritizing variants of uncertain significance (VUS) identified by comprehensive genomic profiling (CGP), based on real-world data from 2,172 tests s

Updated on:June 09,2026

Early results from a trial of active surveillance for low-risk ductal carcinoma in situ are 'reassuring'

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described ear

Updated on: May 30,2026

Early results from a trial of active surveillance for low-risk ductal carcinoma in situ are 'reassuring'

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described ear

Updated on:May 30,2026

'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer

by Ananya Sen,University of MichiganCredit: Jacob Dwyer, Justine Ross, Michigan MedicineLung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80

Updated on: December 28,2025

'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer

by Ananya Sen,University of MichiganCredit: Jacob Dwyer, Justine Ross, Michigan MedicineLung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80

Updated on:December 28,2025

Pesticides and cancer: Study reveals the biological mechanisms behind an environmental health risk

byPasteur InstituteCredit: Mark Stebnicki from PexelsA new study, published inNature Health, reveals a strong link between exposure to agricultural pesticides in the environment and the risk of develo

Updated on: June 02,2026

Pesticides and cancer: Study reveals the biological mechanisms behind an environmental health risk

byPasteur InstituteCredit: Mark Stebnicki from PexelsA new study, published inNature Health, reveals a strong link between exposure to agricultural pesticides in the environment and the risk of develo

Updated on:June 02,2026

AI model can predict chemotherapy benefit in breast cancer

byTechnion - Israel Institute of TechnologyStudy cohorts, deep learning system architecture, and performance evaluation on TAILORx-Test. Credit:The Lancet Oncology(2026). DOI: 10.1016/s1470-2045(25)00

Updated on: May 29,2026

AI model can predict chemotherapy benefit in breast cancer

byTechnion - Israel Institute of TechnologyStudy cohorts, deep learning system architecture, and performance evaluation on TAILORx-Test. Credit:The Lancet Oncology(2026). DOI: 10.1016/s1470-2045(25)00

Updated on:May 29,2026

AI learns to make sense of childhood cancer survivors' health care needs

bySt. Jude Children's Research HospitalCredit: SHVETS production from PexelsArtificial intelligence (AI) could help physicians determine if survivors of childhood cancer need extra support—and the

Updated on: May 28,2026

AI learns to make sense of childhood cancer survivors' health care needs

bySt. Jude Children's Research HospitalCredit: SHVETS production from PexelsArtificial intelligence (AI) could help physicians determine if survivors of childhood cancer need extra support—and the

Updated on:May 28,2026

DOCK10 emerges as key trigger of dangerous insulin hypersecretion in rare pancreatic tumors

byInstitute of Science TokyoThe dedicator of cytokinesis 10 (DOCK10) gene has been identified as a key driver of abnormal insulin secretion in insulinomas, as reported by researchers from Institute of

Updated on: April 16,2026

DOCK10 emerges as key trigger of dangerous insulin hypersecretion in rare pancreatic tumors

byInstitute of Science TokyoThe dedicator of cytokinesis 10 (DOCK10) gene has been identified as a key driver of abnormal insulin secretion in insulinomas, as reported by researchers from Institute of

Updated on:April 16,2026

3 million-cell map shows menopause reshapes breast tissue, possibly raising cancer risk

byUniversity of CambridgeCredit: RDNE Stock project from PexelsScientists have created the most detailed map to date, comprised of over 3 million cells, showing how breast tissue changes as women age—

Updated on: April 11,2026

3 million-cell map shows menopause reshapes breast tissue, possibly raising cancer risk

byUniversity of CambridgeCredit: RDNE Stock project from PexelsScientists have created the most detailed map to date, comprised of over 3 million cells, showing how breast tissue changes as women age—

Updated on:April 11,2026

Researchers discover 'crosstalk' mechanism in two key breast cancer molecules

byUniversity of LiverpoolIntegrin αVβ6recruits HER2 and a trafficking regulatory subnetwork comprising RAB5/RAB7A/GDI2 in HER2+ breast cancer cells. Credit:Science Advances(202

Updated on: December 21,2024

Researchers discover 'crosstalk' mechanism in two key breast cancer molecules

byUniversity of LiverpoolIntegrin αVβ6recruits HER2 and a trafficking regulatory subnetwork comprising RAB5/RAB7A/GDI2 in HER2+ breast cancer cells. Credit:Science Advances(202

Updated on:December 21,2024

Gene modification can encourage T cell growth, improving cancer treatment's success rate

Updated on: March 25,2025

Gene modification can encourage T cell growth, improving cancer treatment's success rate

Updated on:March 25,2025

Researchers discover short form of a tumor-produced protein activates natural killer cells

Updated on: March 27,2025

Researchers discover short form of a tumor-produced protein activates natural killer cells

Updated on:March 27,2025